Over the course of the year so far, Enzolytics Inc (OTCMKTS:ENZC) has been one of the more popular stocks among penny stock investors and it has returned considerable gains as well. However, over the course of the past week the situation has been quite different for the Enzolytics stock as it lost as much as 9% during that period.
That being said, it should also be kept in mind that there has been no news about the company in the past week and hence, the decline might appear a bit random for some observers.
The last important news with regards to Enzolytics actually emerged on July 26, 2021, when the company announced that it appointed Steve Sharabura as the President of RobustoMed Inc, its fully owned subsidiary company based out of Atlanta. It is a key appointment for RobustoMed considering the fact that the company is going to embark on a new business model altogether that is going to be focussed on global partnerships.
The partnerships are going to be focussed on the possibility of medicines that are still at the development stage. Sharabura possesses considerable international experience and is going to play a major role in the next chapter for RobustoMed.
